Compile Data Set for Download or QSAR
Report error Found 101 Enz. Inhib. hit(s) with all data for entry = 7302
TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624090BDBM50624090(CHEMBL5411357 | US20260035340, Compound A1-a)
Affinity DataIC50: 40nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624119BDBM50624119(CHEMBL5432550 | US20260035340, Compound A1-u)
Affinity DataIC50: 50nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624095BDBM50624095(CHEMBL5417484 | US20260035340, Compound A1-f)
Affinity DataIC50: 50nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624116BDBM50624116(CHEMBL5436074 | US20260035340, Compound A1-r)
Affinity DataIC50: 51nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624093BDBM50624093(CHEMBL5437220 | US20260035340, Compound A1-d)
Affinity DataIC50: 60nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624092BDBM50624092(CHEMBL5412889 | US20260035340, Compound A1-c)
Affinity DataIC50: 60nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 791004BDBM791004(US20260035340, Compound Ref)
Affinity DataIC50: 70nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624094BDBM50624094(CHEMBL5405662 | US20260035340, Compound A1-e)
Affinity DataIC50: 70nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624125BDBM50624125(CHEMBL5409789 | US20260035340, Compound A1-aa)
Affinity DataIC50: 80nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 791033BDBM791033((E)-3-(3-((4-methylbenzyl)carbamoyl)-5-((3-methylb...)
Affinity DataIC50: 80nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624091BDBM50624091(CHEMBL5402185 | US20260035340, Compound A1-b)
Affinity DataIC50: 90nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624106BDBM50624106(CHEMBL5401206 | US20260035340, Compound A1-q)
Affinity DataIC50: 94nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624103BDBM50624103(CHEMBL5427873 | US20260035340, Compound A1-n)
Affinity DataIC50: 94nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624098BDBM50624098(CHEMBL5407493 | US20260035340, Compound A1-i)
Affinity DataIC50: 100nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624104BDBM50624104(CHEMBL5440460 | US20260035340, Compound A1-o)
Affinity DataIC50: 100nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624124BDBM50624124(CHEMBL5403375 | US20260035340, Compound A1-z)
Affinity DataIC50: 110nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624105BDBM50624105(CHEMBL5408308 | US20260035340, Compound A1-p)
Affinity DataIC50: 110nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624118BDBM50624118(CHEMBL5408158 | US20260035340, Compound A1-t)
Affinity DataIC50: 110nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624117BDBM50624117(CHEMBL5411768 | US20260035340, Compound A1-s)
Affinity DataIC50: 110nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624096BDBM50624096(CHEMBL5397612 | US20260035340, Compound A1-g)
Affinity DataIC50: 130nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624120BDBM50624120(CHEMBL5422271 | US20260035340, Compound A1-v)
Affinity DataIC50: 140nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624113BDBM50624113(CHEMBL5436263 | US20260035340, Compound 15)
Affinity DataIC50: 170nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624102BDBM50624102(CHEMBL5438117 | US20260035340, Compound A1-m)
Affinity DataIC50: 170nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624101BDBM50624101(CHEMBL5421383 | US20260035340, Compound A1-l)
Affinity DataIC50: 170nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624121BDBM50624121(CHEMBL5412832 | US20260035340, Compound A1-w)
Affinity DataIC50: 180nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624099BDBM50624099(CHEMBL5411601 | US20260035340, Compound A1-j)
Affinity DataIC50: 190nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624100BDBM50624100(CHEMBL5427049 | US20260035340, Compound A1-k)
Affinity DataIC50: 190nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624097BDBM50624097(CHEMBL5403238 | US20260035340, Compound A1-h)
Affinity DataIC50: 200nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624109BDBM50624109(CHEMBL5425839 | US20260035340, Compound 3)
Affinity DataIC50: 200nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624128BDBM50624128(CHEMBL5406207 | US20260035340, Compound 11)
Affinity DataIC50: 300nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624123BDBM50624123(CHEMBL5402839 | US20260035340, Compound A1-y)
Affinity DataIC50: 330nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624112BDBM50624112(CHEMBL5397146 | US20260035340, Compound 14)
Affinity DataIC50: 400nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624126BDBM50624126(CHEMBL5441078 | US20260035340, Compound A1-bb)
Affinity DataIC50: 500nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624122BDBM50624122(CHEMBL5424035 | US20260035340, Compound A1-x)
Affinity DataIC50: 880nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624114BDBM50624114(CHEMBL5438808 | US20260035340, Compound 16a)
Affinity DataIC50: 1.40E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C4(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624119BDBM50624119(CHEMBL5432550 | US20260035340, Compound A1-u)
Affinity DataIC50: 2.40E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624111BDBM50624111(CHEMBL5410143 | US20260035340, Compound 13)
Affinity DataIC50: 2.70E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 791041BDBM791041((E)-3-(2-Cyanovinyl)-N-(4-methylbenzyl)-5-(3-methy...)
Affinity DataIC50: 2.70E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C2(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624103BDBM50624103(CHEMBL5427873 | US20260035340, Compound A1-n)
Affinity DataIC50: 4.80E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C2(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624123BDBM50624123(CHEMBL5402839 | US20260035340, Compound A1-y)
Affinity DataIC50: 5.10E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C4(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624092BDBM50624092(CHEMBL5412889 | US20260035340, Compound A1-c)
Affinity DataIC50: 6.00E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C4(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624104BDBM50624104(CHEMBL5440460 | US20260035340, Compound A1-o)
Affinity DataIC50: 6.10E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C4(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624091BDBM50624091(CHEMBL5402185 | US20260035340, Compound A1-b)
Affinity DataIC50: 6.50E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C4(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624093BDBM50624093(CHEMBL5437220 | US20260035340, Compound A1-d)
Affinity DataIC50: 8.00E+3nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C4(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624098BDBM50624098(CHEMBL5407493 | US20260035340, Compound A1-i)
Affinity DataIC50: 1.00E+4nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C2(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624121BDBM50624121(CHEMBL5412832 | US20260035340, Compound A1-w)
Affinity DataIC50: 1.10E+4nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C4(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624120BDBM50624120(CHEMBL5422271 | US20260035340, Compound A1-v)
Affinity DataIC50: 1.10E+4nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C2(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624105BDBM50624105(CHEMBL5408308 | US20260035340, Compound A1-p)
Affinity DataIC50: 1.20E+4nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C2(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624106BDBM50624106(CHEMBL5401206 | US20260035340, Compound A1-q)
Affinity DataIC50: 1.25E+4nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C2(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 50624104BDBM50624104(CHEMBL5440460 | US20260035340, Compound A1-o)
Affinity DataIC50: 1.40E+4nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

Displayed 1 to 50 (of 101 total ) | Next | Last >>
Jump to: